Medtech Execs On The Move, September 2014
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
You may also be interested in...
Santhera Pharmaceuticals’ vamorolone for treating Duchenne muscular dystrophy is among the latest medicines that have been submitted for review for potential pan-EU approval.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
A busy October will include planned biosimilar launches and key appointments for the off-patent sector.